Charles River Laboratories International, Inc. Stock
Charles River Laboratories International, Inc. Stock price
Key metrics
Is Charles River Laboratories International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.
Charles River Laboratories International, Inc. Stock Analysis
Analyst Opinions
24 Analysts have issued a Charles River Laboratories International, Inc. forecast:
Analyst Opinions
24 Analysts have issued a Charles River Laboratories International, Inc. forecast:
Financial data from Charles River Laboratories International, Inc.
| Mar '25 |
+/-
%
|
||
| Revenue | 4,023 4,023 |
2%
2%
|
|
| Gross Profit | 1,395 1,395 |
7%
7%
|
|
| EBITDA | 678 678 |
11%
11%
|
EBIT (Operating Income) EBIT | 506 506 |
19%
19%
|
| Net Profit | -32 -32 |
107%
107%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Charles River Laboratories International, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Charles River Laboratories International, Inc. Stock News
Company Profile
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
| Head office | United States |
| CEO | James Foster |
| Employees | 19,400 |
| Founded | 1947 |
| Website | www.criver.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
